Cargando…

Nephrogenic Systemic Fibrosis in Denmark– A Nationwide Investigation

BACKGROUND: Nephrogenic systemic fibrosis is a debilitating and painful disorder with an increased stimulation of the connective tissue in the skin and systemic tissues. The disease is associated with exposure to gadolinium-based contrast agent used in magnetic resonance imaging in patients with ren...

Descripción completa

Detalles Bibliográficos
Autores principales: Elmholdt, Tina R., Olesen, Anne B. B., Jørgensen, Bettina, Kvist, Stinne, Skov, Lone, Thomsen, Henrik S., Marckmann, Peter, Pedersen, Michael
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2013
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3857209/
https://www.ncbi.nlm.nih.gov/pubmed/24349178
http://dx.doi.org/10.1371/journal.pone.0082037
_version_ 1782295128986091520
author Elmholdt, Tina R.
Olesen, Anne B. B.
Jørgensen, Bettina
Kvist, Stinne
Skov, Lone
Thomsen, Henrik S.
Marckmann, Peter
Pedersen, Michael
author_facet Elmholdt, Tina R.
Olesen, Anne B. B.
Jørgensen, Bettina
Kvist, Stinne
Skov, Lone
Thomsen, Henrik S.
Marckmann, Peter
Pedersen, Michael
author_sort Elmholdt, Tina R.
collection PubMed
description BACKGROUND: Nephrogenic systemic fibrosis is a debilitating and painful disorder with an increased stimulation of the connective tissue in the skin and systemic tissues. The disease is associated with exposure to gadolinium-based contrast agent used in magnetic resonance imaging in patients with renal impairment. METHODS: The prevalence of nephrogenic systemic fibrosis has so far never been determined at a national level. In 2009, Denmark was the first country to design a guideline for the tracing of nephrogenic systemic fibrosis patients. The aim of this paper is to communicate the main findings of this quest. RESULTS: The outcome of the nationwide investigation revealed that Denmark had 65 patients with nephrogenic systemic fibrosis and thereby the highest prevalence of nephrogenic systemic fibrosis worldwide with 65 per 5.6 million inhabitants, or 12 per million. CONCLUSIONS: The nationwide investigation in Denmark revealed the highest prevalence of NSF worldwide. This may be rooted in a high level of awareness of NSF both among doctors, politicians and, not least, the media, combined with the fact that a nationwide NSF investigation was initiated.
format Online
Article
Text
id pubmed-3857209
institution National Center for Biotechnology Information
language English
publishDate 2013
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-38572092013-12-13 Nephrogenic Systemic Fibrosis in Denmark– A Nationwide Investigation Elmholdt, Tina R. Olesen, Anne B. B. Jørgensen, Bettina Kvist, Stinne Skov, Lone Thomsen, Henrik S. Marckmann, Peter Pedersen, Michael PLoS One Research Article BACKGROUND: Nephrogenic systemic fibrosis is a debilitating and painful disorder with an increased stimulation of the connective tissue in the skin and systemic tissues. The disease is associated with exposure to gadolinium-based contrast agent used in magnetic resonance imaging in patients with renal impairment. METHODS: The prevalence of nephrogenic systemic fibrosis has so far never been determined at a national level. In 2009, Denmark was the first country to design a guideline for the tracing of nephrogenic systemic fibrosis patients. The aim of this paper is to communicate the main findings of this quest. RESULTS: The outcome of the nationwide investigation revealed that Denmark had 65 patients with nephrogenic systemic fibrosis and thereby the highest prevalence of nephrogenic systemic fibrosis worldwide with 65 per 5.6 million inhabitants, or 12 per million. CONCLUSIONS: The nationwide investigation in Denmark revealed the highest prevalence of NSF worldwide. This may be rooted in a high level of awareness of NSF both among doctors, politicians and, not least, the media, combined with the fact that a nationwide NSF investigation was initiated. Public Library of Science 2013-12-09 /pmc/articles/PMC3857209/ /pubmed/24349178 http://dx.doi.org/10.1371/journal.pone.0082037 Text en © 2013 Elmholdt et al http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly credited.
spellingShingle Research Article
Elmholdt, Tina R.
Olesen, Anne B. B.
Jørgensen, Bettina
Kvist, Stinne
Skov, Lone
Thomsen, Henrik S.
Marckmann, Peter
Pedersen, Michael
Nephrogenic Systemic Fibrosis in Denmark– A Nationwide Investigation
title Nephrogenic Systemic Fibrosis in Denmark– A Nationwide Investigation
title_full Nephrogenic Systemic Fibrosis in Denmark– A Nationwide Investigation
title_fullStr Nephrogenic Systemic Fibrosis in Denmark– A Nationwide Investigation
title_full_unstemmed Nephrogenic Systemic Fibrosis in Denmark– A Nationwide Investigation
title_short Nephrogenic Systemic Fibrosis in Denmark– A Nationwide Investigation
title_sort nephrogenic systemic fibrosis in denmark– a nationwide investigation
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3857209/
https://www.ncbi.nlm.nih.gov/pubmed/24349178
http://dx.doi.org/10.1371/journal.pone.0082037
work_keys_str_mv AT elmholdttinar nephrogenicsystemicfibrosisindenmarkanationwideinvestigation
AT olesenannebb nephrogenicsystemicfibrosisindenmarkanationwideinvestigation
AT jørgensenbettina nephrogenicsystemicfibrosisindenmarkanationwideinvestigation
AT kviststinne nephrogenicsystemicfibrosisindenmarkanationwideinvestigation
AT skovlone nephrogenicsystemicfibrosisindenmarkanationwideinvestigation
AT thomsenhenriks nephrogenicsystemicfibrosisindenmarkanationwideinvestigation
AT marckmannpeter nephrogenicsystemicfibrosisindenmarkanationwideinvestigation
AT pedersenmichael nephrogenicsystemicfibrosisindenmarkanationwideinvestigation